BR9608912A - Agonistas de meletonina para o tratamento de hiperplasia prostática benigna - Google Patents

Agonistas de meletonina para o tratamento de hiperplasia prostática benigna

Info

Publication number
BR9608912A
BR9608912A BR9608912A BR9608912A BR9608912A BR 9608912 A BR9608912 A BR 9608912A BR 9608912 A BR9608912 A BR 9608912A BR 9608912 A BR9608912 A BR 9608912A BR 9608912 A BR9608912 A BR 9608912A
Authority
BR
Brazil
Prior art keywords
meletonin
agonists
treatment
benign prostatic
prostatic hyperplasia
Prior art date
Application number
BR9608912A
Other languages
English (en)
Inventor
David Oakley Clarke
Lisa Ann Shipley
William Henry Jordan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9608912A publication Critical patent/BR9608912A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
BR9608912A 1995-06-14 1996-06-12 Agonistas de meletonina para o tratamento de hiperplasia prostática benigna BR9608912A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20395P 1995-06-14 1995-06-14
PCT/US1996/010135 WO1997000069A1 (en) 1995-06-14 1996-06-12 Melatonin agonists for treating benign prostatic hyperplasia

Publications (1)

Publication Number Publication Date
BR9608912A true BR9608912A (pt) 1999-03-02

Family

ID=21690383

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608912A BR9608912A (pt) 1995-06-14 1996-06-12 Agonistas de meletonina para o tratamento de hiperplasia prostática benigna

Country Status (17)

Country Link
US (1) US5770610A (pt)
EP (1) EP0748627A3 (pt)
JP (1) JPH11507671A (pt)
KR (1) KR19990022917A (pt)
CN (1) CN1191484A (pt)
AU (1) AU719501B2 (pt)
BR (1) BR9608912A (pt)
CA (1) CA2224649A1 (pt)
CZ (1) CZ400597A3 (pt)
EA (1) EA000946B1 (pt)
HU (1) HUP9901139A3 (pt)
IL (1) IL122316A0 (pt)
NO (1) NO975838L (pt)
NZ (1) NZ310852A (pt)
PL (1) PL324172A1 (pt)
TR (1) TR199701613T1 (pt)
WO (1) WO1997000069A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL144900A (en) 2001-08-14 2013-12-31 Neurim Pharma 1991 Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs
KR101041075B1 (ko) 2004-11-11 2011-06-13 삼성전자주식회사 광픽업 장치
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3105850A1 (de) * 1981-02-18 1982-08-19 Horst, Hans Jörg, Priv.Doz.Dr., 2057 Reinbek Mittel zum behandeln von tumoren
US4600723A (en) * 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
US4614807A (en) * 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
US4997845A (en) * 1987-02-02 1991-03-05 Eli Lilly And Company β-alkylmelatonins as ovulation inhibitors
DE3867957D1 (de) * 1987-08-05 1992-03-05 Daikin Ind Ltd Modifiziertes polytetrafluoraethylen und verfahren zu seiner herstellung.
US5242941A (en) * 1990-12-04 1993-09-07 State Of Oregon Methods of treating circadian rhythm disorders
IT222859Z2 (it) * 1991-08-01 1995-05-08 Bartolomeo Assenza Complesso osteointegrato costituito da un perno e da un collare intercambiabile avente l'altezza scelta in base allo spessore dello strato mucoso connettivale epiteliale del paziente
US5196435A (en) * 1991-11-21 1993-03-23 Eli Lilly And Company Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
ATE141051T1 (de) * 1992-04-07 1996-08-15 Neurim Pharma 1991 Verwendung von melatonin zur herstellung eines arzneimittels zur behandlung der gutartigen prostatahyperplasie
US5654325A (en) * 1993-11-18 1997-08-05 Eli Lilly And Company Melatonin derivatives for use in treating sleep disorders
US6180657B1 (en) * 1993-11-18 2001-01-30 Eli Lilly And Company Melatonin derivatives for use in treating desynchronization disorders
GB9407919D0 (en) * 1994-04-21 1994-06-15 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
KR19990022917A (ko) 1999-03-25
WO1997000069A1 (en) 1997-01-03
EP0748627A3 (en) 1997-05-21
JPH11507671A (ja) 1999-07-06
AU719501B2 (en) 2000-05-11
CA2224649A1 (en) 1997-01-03
IL122316A0 (en) 1998-04-05
EP0748627A2 (en) 1996-12-18
TR199701613T1 (xx) 1998-04-21
HUP9901139A2 (hu) 1999-08-30
EA199800058A1 (ru) 1998-08-27
CZ400597A3 (cs) 1998-07-15
AU6172896A (en) 1997-01-15
CN1191484A (zh) 1998-08-26
NO975838D0 (no) 1997-12-11
EA000946B1 (ru) 2000-06-26
NZ310852A (en) 2000-07-28
PL324172A1 (en) 1998-05-11
NO975838L (no) 1998-01-12
HUP9901139A3 (en) 2000-01-28
US5770610A (en) 1998-06-23

Similar Documents

Publication Publication Date Title
BR9608651A (pt) Método para o tratamento de hiperplasia prostática benigna com terapia térmica
DE60023982D1 (de) System zur Behandlung von benigner Prostatahyperplasie
NO993396L (no) Kinolin- og kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi
BR9508886A (pt) Compostos e métodos para o tratamento de câncer
PT977748E (pt) Derivados benzopirano substituidos para o tratamento de inflamacao
BR9603841A (pt) Aparelho para o tratamento hipertérmico de tumores
NO984431D0 (no) FremgangsmÕte for behandling av smerte
NO985652D0 (no) Anvendelse av naaladaseinhibitorer ved behandling av kreft
EE04416B1 (et) a1L- agonistide kasutamine uriiniinkontinentsuse raviks
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
DK0925069T3 (da) Anvendelse af Cetrorelix til behandling af godartet prostatahypertrofi og prostatacancer
ATE239509T1 (de) Konjugate zur behandlung von prostatakrebs
PT752870E (pt) Utilizacao de mycobacterium para o tratamento de tumores
BR9612283A (pt) Composição para o tratamento de manchas em peças de roupa e métodos de tratamento
EP0855910A4 (en) CONJUGATES USEFUL FOR TREATING BENIN PROSTATIC ADENOMA
NO984446D0 (no) FremgangsmÕte for behandling av smerte
PT984777E (pt) Piperazinas arilsubstituidas uteis no tratamento da hiperplasia benigna da prostata
PT853959E (pt) Composicao para o tratamento do amianto
NO984432D0 (no) FremgangsmÕte for behandling av migrenesmerte
ZA982819B (en) Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogn receptor modulators.
ATE250580T1 (de) Substituierte pyridino-arylpiperazine zur behandlung benigner prostatahyperplasie
BR9608912A (pt) Agonistas de meletonina para o tratamento de hiperplasia prostática benigna
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
IT1283124B1 (it) Forme e composizioni farmaceutiche per il trattamento dell'ipertrofia prostatica benigna
ID19472A (id) Formulasi perbaikan baru untuk pengobatan tromboembolisme

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
B09B Patent application refused [chapter 9.2 patent gazette]